“…Among them, compounds 43 and 44 were the most active against H1N1 rimantadine-resistant virus A/PR/8/34 (CTD 50 = 683.7 μM), more potent than the reference rimantadine (CTD 50 = 379.8 μM), suggesting that they might have potential for further development as new effective anti-influenza drugs. 65 The bioactive triterpene saponin saikosaponin A (45) from Bupleurum chinense effectively attenuated IAV replication, including that of the highly pathogenic H5N1 strain, in human alveolar epithelial A549 cells via down regulation of both IAV-induced NF-κB activation and caspase 3-dependent NP nuclear translocation. Critically, it also protected against lethal PR8-induced mortality and morbidity in vivo through the reduction but not complete elimination of lung neutrophil and monocyte recruitment.…”